Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9931373
SERIAL NO

14561573

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are pharmaceutical and synergistic compositions human recombinant alpha-fetoprotein expressed in eukaryotic cells for preparation of therapeutic agents for use in oncology, immunotherapy, stem cell therapy, and cosmetology and also for the diagnosis of cancer and embryogenic pathologies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DUDICH IGORNot Provided

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dudich, Elena Moskovskaya Oblast, RU 3 0
Dudich, Igor Moskovskaya Oblast, RU 2 0
Semenkova, Lydia Moskovskaya Oblast, RU 2 0
Tatulov, Eduard Moskow, RU 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 3, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00